Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies. Allman M, Tallantyre E, Robertson NP. J Neurol 2022 Mar 14. pii: 10.1007/s00415-022-11053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Allman M, Tallantyre E, Robertson NP. Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies. J Neurol 2022 Mar 14. pii: 10.1007/s00415-022-11053.
PMID: 35286479